Joe is a man of vision. This is what I see he is
Joe is a man of vision. This is what I see he is doing:
He is putting together a multi-faceted medical service organization on a grand scale worth billions of dollars. Each piece of the company itself could be worth billions like the HMOs started or supported by Dr Patel.
Joe has surrounded himself with high caliber people like Terry Thompson, Dr Patel, ..dealing with multi-billion dollar companies and who have proven themselves.
Joe is not looking at uplisting for the sake of uplisting. He wants to be on Nasdaq for all the benefits already mentioned. He sees GNBT worth billions. I used to think that GNBT could trade at $100. I now can see where it may trade past $200.
Call me crazy, but if Joe can accomplish everything that he has been saying in the CC and in these PR's, I don't see why not.
It's understandable not to put much credence in what I say, but so far Joe has done everything he said he is going to do. Surround himself with proven people and organizations.
Yes, we see the failed pharmacies, Veneto is not quite what it's supposed to be. But if those companies were totally healthy, Generex would have no chance of even being mentioned in the same breath as those companies.
But this is an opportunity that Joe is seizing to the fullest. I believe in him,.
Again, I don't claim to know everything that's on this mind, but this is what I see he is doing.
And most of all, Joe wants those who suffered under the old management to benefit from what he is doing now. That's why he is giving us those dividends. He never forgets us.
I am very thankful to him. Again, call me crazy. I don't believe that he is playing tricks on us, etc... He is trying his best. And the hiccups are normal and should be recognized and accepted. To keep bringing doubts to what he is trying to do is really an insult to him, especially if he is sincere in his heart that he wants the best for us. And I believe wholeheartedly that he does.
May God bless him and continue to protect him and his family. We saw he needed it.
3
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...
Continue Reading
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...
Continue Reading
Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...
Continue Reading
Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...
Continue Reading
Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...
Continue Reading
Top 5 Most Recently Viewed Articles
Hamilton ETFs Unveils a New Investment Strategy Hamilton Capital Partners Inc. ("Hamilton ETFs") is excited to announce the launch of its newest product, the Hamilton U.S. T-Bill YIELD MAXIMIZER™ ETF ("HBIL"). This fund aims to offer investors appealing monthly income by primarily investing in stable, shorter-term U.S. Treasury securities. Key Benefits of the HBIL ETF A...
Continue Reading
Celebrating a Legacy of Innovation Pacific Software Publishing, Inc. (PSPINC) proudly celebrates its 38th anniversary this month, highlighting nearly four decades of dedication and advancement in the software and internet sectors. The Evolution of PSPINC Founded in 1987, PSPINC started as a software export business before transforming into a company specializing in...
Continue Reading
ANI Pharmaceuticals Set to Present at Major Healthcare Conference ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is excited to announce its participation in the upcoming Jefferies Global Healthcare Conference. Nikhil Lalwani, the Chief Executive Officer, will lead the presentation, highlighting the company's innovative approaches to biopharmaceuticals. Event Details and...
Continue Reading
Truist Financial Corporation Declares Shareholder Dividends Truist Financial Corporation (NYSE: TFC) has officially announced dividends for both its common and preferred shares. This declaration marks a significant moment for the company, as they continue to prioritize shareholder value amidst a robust financial environment. Details on the Dividend Payments The regular...
Continue Reading
Rising Customer Satisfaction in Canada’s Banking Sector Recent reports indicate an encouraging shift in customer satisfaction among Canadian banks. According to the J.D. Power 2024 Canada Retail Banking Satisfaction Study, we have witnessed a notable rebound in the way customers perceive their main banking institutions. The study reveals an 8-point increase in overall...
Continue Reading